Biolinerx Stock Probability of Future Stock Price Finishing Over 4.47
| BLRX Stock | USD 4.47 0.18 3.87% |
BioLineRx | Build AI portfolio with BioLineRx Stock |
BioLineRx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioLineRx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioLineRx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioLineRx is way too risky over 90 days horizon | |
| BioLineRx appears to be risky and price may revert if volatility continues | |
| BioLineRx has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 28.94 M. Net Loss for the year was (9.22 M) with profit before overhead, payroll, taxes, and interest of 14.5 M. | |
| BioLineRx currently holds about 43.15 M in cash with (43.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9. | |
| BioLineRx has a very weak financial position based on the latest SEC disclosures |
BioLineRx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioLineRx Stock often depends not only on the future outlook of the current and potential BioLineRx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioLineRx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.9 M | |
| Cash And Short Term Investments | 19.6 M |
BioLineRx Technical Analysis
BioLineRx's future price can be derived by breaking down and analyzing its technical indicators over time. BioLineRx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioLineRx. In general, you should focus on analyzing BioLineRx Stock price patterns and their correlations with different microeconomic environments and drivers.
BioLineRx Predictive Forecast Models
BioLineRx's time-series forecasting models is one of many BioLineRx's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioLineRx's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BioLineRx
Checking the ongoing alerts about BioLineRx for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioLineRx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BioLineRx is way too risky over 90 days horizon | |
| BioLineRx appears to be risky and price may revert if volatility continues | |
| BioLineRx has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 28.94 M. Net Loss for the year was (9.22 M) with profit before overhead, payroll, taxes, and interest of 14.5 M. | |
| BioLineRx currently holds about 43.15 M in cash with (43.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9. | |
| BioLineRx has a very weak financial position based on the latest SEC disclosures |
Additional Tools for BioLineRx Stock Analysis
When running BioLineRx's price analysis, check to measure BioLineRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLineRx is operating at the current time. Most of BioLineRx's value examination focuses on studying past and present price action to predict the probability of BioLineRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLineRx's price. Additionally, you may evaluate how the addition of BioLineRx to your portfolios can decrease your overall portfolio volatility.